Skip to content
  1. Home
  2. Latest news
  3. What you need to know about Johnson & Johnson’s 2024 fourth-quarter and full-year earnings report
Q42024 lede-r2.png

What you need to know about Johnson & Johnson’s 2024 fourth-quarter and full-year earnings report

Check out this infographic breakdown of the company’s fourth-quarter and full-year performance, with highlights from its Innovative Medicine and MedTech businesses.

This morning, Johnson & Johnson shared its 2024 fourth-quarter and full-year earnings report.

Since its founding in 1886, the company has been committed to innovation—today, more than 130,000 employees across the globe work to deliver solutions for patients around the world to help profoundly impact health for humanity.

“Johnson & Johnson delivered another year of solid results in 2024, marked by strategically important investments while advancing the pipelines of both our Innovative Medicine and MedTech businesses,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We begin 2025 focused on bringing new treatments and innovations to patients, delivering on our near- and long-term financial targets and creating value for our shareholders.”

For more details about the company’s 2024 fourth-quarter and full-year results, and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.

FINAL_Q4 2024 Earnings Infographic_Web version for jnj.com article.jpg

Johnson & Johnson’s 2024 Earnings

Read the earnings press release, which includes fourth-quarter and full-year financial data for 2024.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

More from Johnson & Johnson

Johnson & Johnson named a 2025 Fortune World’s Most Admired Company

A dedication to innovation and social responsibility are just two of the qualities that helped the company garner a coveted spot on the list for the 23rd year in a row.

Terra Kremer, Ph.D., is on a mission to create self-sterilizing surgical tools

Since its launch, Johnson & Johnson has focused on helping make surgeries safer. Learn how this analytical microbiologist and her team are continuing in that tradition with a digital app that aims to change the way medical devices are designed and sterilized.

What is lupus?

Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.